Atorvastatin strontium

This classification denotes a hmg-coa reductase inhibitor 2C33H34FN2O5.Sr, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AMJ4WWI6NM, chemically known as h-pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-.beta.,.delta.-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-, strontium salt (2:1), (.beta.r,.delta.r)-, but more generally known as atorvastatin strontium, which bears US NIH Compound Identifier 24875347. Most nations, for tariff and trade purposes, schedule atorvastatin strontium under HS 29339990 and SITC 51577. As of Q4 2014, ATORVASTATIN STRONTIUM remains US FDA's Preferred Term for this commodity. SMILES: CC(C)C1C(C(C(N1CC[C@H](C[C@H](CC(=O)[O-])O)O)C2CCC(CC2)F)C3CCCCC3)C(=O)NC4CCCCC4.CC(C)C1C(C(C(N1CC[C@H](C[C@H](CC(=O)[O-])O)O)C2CCC(CC2)F)C3CCCCC3)C(=O)NC4CCCCC4.[SR+2].